5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 5.50▲ | 5.44▲ | 5.46▲ | 5.18▲ | 4.92▲ |
MA10 | 5.46▲ | 5.45▲ | 5.40▲ | 5.10▲ | 4.67▲ |
MA20 | 5.43▲ | 5.39▲ | 5.33▲ | 4.98▲ | 4.64▲ |
MA50 | 5.44▲ | 5.29▲ | 5.02▲ | 4.65▲ | 6.76▼ |
MA100 | 5.41▲ | 5.03▲ | 5.11▲ | 4.56▲ | 9.60▼ |
MA200 | 5.32▲ | 5.08▲ | 4.88▲ | 5.76▼ | 8.03▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.014▲ | -0.003▼ | 0.006▲ | 0.033▲ | 0.254▲ |
RSI | 70.571▲ | 63.417▲ | 65.295▲ | 63.066▲ | 52.069▲ |
STOCH | 97.327▲ | 53.551 | 77.021 | 51.070 | 58.551 |
WILL %R | -6.667▲ | -7.143▲ | -5.333▲ | -12.605▲ | -8.475▲ |
CCI | 118.335▲ | 84.950 | 91.417 | 105.552▲ | 116.649▲ |
CDL | $OLMA Marubozu Candlestick Pattern Detected | Set Alert |
Thursday, August 14, 2025 10:08 AM
Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC) has officially entered the most critical phase of its development journey—pursuing a potential registration-enabling trial in first-line metastatic ...
|
Tuesday, August 12, 2025 10:38 PM
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is one of the 11 Best Short-Term Stocks to Invest in. The company sees its Buy rating reiterated following promising results from its clinical trials, ...
|
Monday, August 11, 2025 01:17 PM
Selected 90 mg once-daily palazestrant for Part 2 of the OPERA-01 Phase 3 monotherapy trial and for the OPERA-02 Phase 3 trial in combination with ribociclibOPERA-01 enrollment ongoing with top-line ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 5.30 | 5.54 | 5.29 | 5.51 | 439,776 |
14/08/25 | 5.27 | 5.35 | 5.15 | 5.26 | 415,952 |
13/08/25 | 5.31 | 5.47 | 5.13 | 5.27 | 579,079 |
12/08/25 | 4.93 | 5.58 | 4.91 | 5.31 | 1,400,252 |
11/08/25 | 4.64 | 4.7786 | 4.47 | 4.57 | 315,299 |
08/08/25 | 4.74 | 4.825 | 4.57 | 4.64 | 515,170 |
07/08/25 | 5.00 | 5.10 | 4.67 | 4.72 | 388,047 |
06/08/25 | 5.31 | 5.36 | 4.98 | 4.98 | 469,979 |
05/08/25 | 5.35 | 5.66 | 5.27 | 5.37 | 772,124 |
04/08/25 | 5.33 | 5.47 | 5.08 | 5.41 | 513,506 |
|
|
||||
|
|
||||
|
|